Kyinno Biotechnology Closes RMB 250M Series B for Bispecific Antibody Pipeline
Kyinno Biotechnology, a China‑based biotech company, announced the completion of its Series B financing round...
Kyinno Biotechnology, a China‑based biotech company, announced the completion of its Series B financing round...
At the 7th China International Import Expo (CIIE), Chinese firms Beijing Mabworks Biotech Co., Ltd,...